Search by
Projects In Knowledge
Home | About Us | News | Collaborators | My PIK | Sign In | Contact Us
| Course Title | Curriculum | Faculty | Release Date | |
|---|---|---|---|---|
|
Expert Insight Into: Anti-VEGF Monoclonal Antibody Plus Taxane-based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer (Part 10 of Series) — |
III | Esteva | Dec 2010 | |
|
Expert Insight Into: Longer Therapy, Amenorrhea, and Breast Cancer (Part 9 of Series) — |
III | Burstein | Nov 2010 | |
|
Expert Insight Into: Prognostic and Predictive Value of a Multigene Tumor Assay in Postmenopausal Women with Node-Positive, Estrogen-Receptor–Positive Breast Cancer on Chemotherapy (Part 8 of Series) — |
III | Carey | Nov 2010 | |
|
Case Study: Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer with Multiple Metastases — |
III | Burstein Carey |
Nov 2010 | |
|
Expert Insight Into: Open Label, Phase II Trial of an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor in Patients with Advanced ErbB2-Positive Breast Cancer (Part 7 of Series) — |
III | Burstein | Oct 2010 | |
|
Breast Cancer Tumor Board Podcast — |
III | Burstein Golshan Bellon |
Sep 2010 | |
|
Expert Insight Into: Selective Serotonin Reuptake Inhibitors and Breast Cancer Mortality in Women Receiving a Selective Estrogen Receptor Modulator (Part 6 of Series) — |
III | Carey | Sep 2010 | |
|
Expert Insight Into: The Combination of Two Anti-HER2 Monoclonal Antibodies in Patients with HER2-Positive Metastatic Breast Cancer that Progressed During Prior Therapy with One of These Agents. (Part 5 of Series) — |
III | Esteva | Aug 2010 | |
|
Expert Insight Into: Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving VEGF Inhibitors. (Part 4 of Series) — |
III | Burstein | Aug 2010 | |
|
Expert Insight Into: Aspirin Intake and Survival After Breast Cancer (Part 3 of Series)
— |
III | Carey | Jul 2010 | |
|
Case Study: Refractory HER2-Positive Metastatic Breast Cancer — |
III | Burstein Esteva |
Jul 2010 | |
|
Expert Insight Into: Recurrence Score for Distant Recurrence Risk in Node-Negative/Node-Positive Postmenopausal Breast Cancer Patients Receiving Hormone Therapy (Part 2 of Series) — |
III | Burstein | Jun 2010 | |
|
Expert Insight Into: Prevention of Aromatase Inhibitor-Induced Bone Loss Using a Bisphosphonate: The SABRE Trial (Part 1 of Series) — |
III | Burstein | Jun 2010 |
Specialties/Topics
Collaborators
News
About Us
Home